Jadebiosciences
Medical Director, Clinical Development(Nephrology)
Boston; San Francisco; Seattle; Vancouver. Posted 3 months ago
The role
The Medical Director in Clinical Development will lead and support clinical programs in nephrology. This role focuses on rare or immune-mediated kidney diseases to advance the company's pipeline.
What you will do
- Lead the design, execution, and oversight of clinical trials in nephrology
- Serve as Medical Monitor for ongoing trials
- Collaborate with clinical operations, regulatory, and biometrics teams
- Educate and advise clinical sites and investigators
- Provide medical expertise to external partners, vendors, and contractors
- Communicate with internal and external stakeholders
- Contribute to the preparation of regulatory documents
- Support interactions with regulatory authorities and ethics committees
- Partner with translational science, biomarker, and commercial teams
- Represent the company at scientific meetings, advisory boards, and industry events
Required qualifications
- MD (or equivalent medical degree)
- 3+ years of experience as a nephrologist in academia or industry, and/or experience in nephrology clinical trials or rare disease programs
- Experience in clinical trial design, execution, and medical monitoring
- Strong clinical judgment, scientific rigor, and regulatory knowledge
- Ability to work independently and thrive in a fast-paced, matrixed environment
- Ability to manage multiple projects simultaneously and prioritize effectively in a fast-paced environment
- Strong analytical, problem-solving, and decision-making skills
- Excellent communication and interpersonal skills
- High ethical standards and impeccable integrity
- Ability to manage complex, confidential, and regulated information
Nice to have
- board certification in nephrology
About the company
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. The company was launched based on assets licensed from Paragon Therapeutics.